ARTICLE | Management Tracks
CFO changes at CRISPR, EQRx, TheracosBio
Plus: Haeberlein leaving Biogen and an update from Ratio
March 14, 2023 12:26 AM UTC
CRISPR Therapeutics AG (NASDAQ:CRSP) hired Raju Prasad as CFO, effective March 14. Raju Prasad was partner and senior equity research analyst at William Blair. He succeeds Brendan Smith, who is leaving to pursue external opportunities.
Jami Rubin is stepping down as CFO of EQRx Inc. (NASDAQ:EQRX) on March 31. EQRx named President and CEO Melanie Nallicheri as principal financial officer while it conducts a search for a successor for Rubin. ...